Gastric cancer immunotherapy:A scientometric and clinical trial review  

作　　者：Qian-Cheng Du Xin-Yu Wang Hua Yu 

机构地区：[1]Thoracic Surgery,Shanghai Xuhui Central Hospital,Shanghai 200031,China [2]Thyroid,Breast and Vascular Surgery,Shanghai Fourth People’s Hospital Affiliated to Tongji University School of Medicine,Shanghai 200434,China [3]Department of General Surgery,Shanghai Fourth People’s Hospital Affiliated to Tongji University School of Medicine,Shanghai 200434,China

出　　处：《World Journal of Gastroenterology》2024年第2期196-198,共3页世界胃肠病学杂志（英文版）

基　　金：the Discipline Promotion Program of Shanghai Fourth People’s Hospital,No.SY-XKZT-2020-1021.

摘　　要：This letter is intended to arouse your interest in a recent review of comprehensive scientometrics and clinical trials on immunotherapy for gastric cancer(GC).Our study reviews recent advances in immunotherapy in the field of GC and highlights its new prospects as a treatment for GC.Our research reveals China’s leadership in this field,as well as new therapeutic strategies such as immune checkpoint inhibitors,cellular immunotherapy,and vaccines.The combined findings highlight the potential of immunotherapy to improve survival and quality of life in patients with stomach cancer.We believe that this study will provide important guidance for the future direction of the GC treatment field.

关 键 词：Gastric cancer IMMUNOTHERAPY BIBLIOMETRICS COMMENT Therapeutic strategies 

分 类 号：R730.51[医药卫生—肿瘤]